Authors: Federico Reali, Anna Fochesato, Chanchala Kaddi, Roberto Visintainer, Shayne Watson, Micha Levi, Véronique Dartois, Karim Azer, Luca Marchetti

Superior Title: Frontiers in Pharmacology, Vol 14 (2024)

Subject Terms: minimal PBPK model, mPBPK, antituberculosis agents, modeling, simulation, tuberculosis, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2023.1272091/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/43f89e564cbe44c49eaf849a38b5aefa

Authors: Keyur R. Parmar, Pradeep B. Lukka, Santosh Wagh, Zaid H. Temrikar, Jiuyu Liu, Richard E. Lee, Miriam Braunstein, Anthony J. Hickey, Gregory T. Robertson, Mercedes Gonzalez-Juarrero, Andrea Edginton, Bernd Meibohm

Superior Title: Pharmaceutics; Volume 15; Issue 6; Pages: 1759

Subject Terms: mPBPK, spectinamides, intratracheal PBPK, subcutaneous PBPK, interspecies extrapolation, granuloma model

File Description: application/pdf

Relation: Pharmacokinetics and Pharmacodynamics; https://dx.doi.org/10.3390/pharmaceutics15061759

Availability: https://doi.org/10.3390/pharmaceutics15061759

Authors: Hardiansyah, Deni, Ng, Chee Meng^{Aff2, IDs11095022032042_cor2}

Superior Title: Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 39(3):481-496

Authors: Federico Reali, Anna Fochesato, Chanchala Kaddi, Roberto Visintainer, Shayne Watson, Micha Levi, Véronique Dartois, Karim Azer, Luca Marchetti

Subject Terms: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, minimal PBPK model, mPBPK, antituberculosis agents, modeling, simulation, tuberculosis, model informed drug development

Relation: https://figshare.com/articles/dataset/DataSheet1_A_minimal_PBPK_model_to_accelerate_preclinical_development_of_drugs_against_tuberculosis_PDF/24939912

Availability: https://doi.org/10.3389/fphar.2023.1272091.s001
https://figshare.com/articles/dataset/DataSheet1_A_minimal_PBPK_model_to_accelerate_preclinical_development_of_drugs_against_tuberculosis_PDF/24939912

Authors: Vivaswath S. Ayyar, Jong Bong Lee, Weirong Wang, Meghan Pryor, Yanli Zhuang, Thomas Wilde, An Vermeulen

Superior Title: Frontiers in Pharmacology, Vol 13 (2022)

Subject Terms: IL-17A, MBMA, mPBPK, psoriasis, target engagement, translational medicine, Therapeutics. Pharmacology, RM1-950

File Description: electronic resource

Relation: https://www.frontiersin.org/articles/10.3389/fphar.2022.862291/full; https://doaj.org/toc/1663-9812

Access URL: https://doaj.org/article/2903032608924a97926dd27ae6f888a7

Authors: Blaise Pasquiers, Salih Benamara, Mathieu Felices, Laurent Nguyen, Xavier Declèves

Superior Title: International Journal of Molecular Sciences; Volume 23; Issue 21; Pages: 12754

Subject Terms: monoclonal antibody, pharmacokinetics, modeling, translational, first-in-human, PopPK, PBPK, mPBPK, ADA

Subject Geographic: agris

File Description: application/pdf

Relation: Molecular Immunology; https://dx.doi.org/10.3390/ijms232112754

Availability: https://doi.org/10.3390/ijms232112754

Authors: Juliano Ferrari Gianlupi, Tarunendu Mapder, T. J. Sego, James P. Sluka, Sara K. Quinney, Morgan Craig, Robert E. Stratford, James A. Glazier

Superior Title: Viruses; Volume 14; Issue 3; Pages: 605

Subject Terms: SARS-CoV-2, antiviral therapy, remdesivir, mPBPK, virtual tissue simulation, agent-based model, multiscale model, tissue model

Subject Geographic: agris

File Description: application/pdf

Relation: General Virology; https://dx.doi.org/10.3390/v14030605

Availability: https://doi.org/10.3390/v14030605

Authors: Gianlupi, Juliano Ferrari, Mapder, Tarunendu, Sego, T.J., Sluka, James P., Quinney, Sara K., Craig, Morgan, Stratford, Robert E., Jr., Glazier, James A.

Contributors: Medicine, School of Medicine

Superior Title: PMC

Subject Terms: SARS-CoV-2, Agent-based model, Antiviral therapy, mPBPK, Multiscale model, Remdesivir, Tissue model, Virtual tissue simulation

File Description: application/pdf

Relation: Viruses; Ferrari Gianlupi J, Mapder T, Sego TJ, et al. Multiscale Model of Antiviral Timing, Potency, and Heterogeneity Effects on an Epithelial Tissue Patch Infected by SARS-CoV-2. Viruses. 2022;14(3):605. Published 2022 Mar 14. doi:10.3390/v14030605; https://hdl.handle.net/1805/33003

Availability: https://doi.org/10.3390/v14030605
https://hdl.handle.net/1805/33003

Authors: Songmao Zheng, Jin Niu, Brian Geist, Damien Fink, Zhenhua Xu, Honghui Zhou, Weirong Wang

Superior Title: mAbs, Vol 12, Iss 1 (2020)

Subject Terms: Inflammatory bowel disease (IBD), anti-TNF mAb, pharmacokinetics (PK), induction dose, minimal physiologically based PK (mPBPK) model, target engagement (TE), Therapeutics. Pharmacology, RM1-950, Immunologic diseases. Allergy, RC581-607

Relation: https://doaj.org/toc/1942-0862; https://doaj.org/toc/1942-0870; https://doaj.org/article/88dc0ad39bff48c0ae6be80ae381adac

Availability: https://doi.org/10.1080/19420862.2020.1813962
https://doaj.org/article/88dc0ad39bff48c0ae6be80ae381adac

Authors: Parmar, Keyur R.

Superior Title: Theses and Dissertations (ETD)

Subject Terms: granuloma model, interspecies extrapolation, intratracheal PBPK, mPBPK, spectinamides, subcutaneous PBPK, Analytical, Diagnostic and Therapeutic Techniques and Equipment, Bacterial Infections and Mycoses, Diseases, Investigative Techniques, Medical Sciences, Medicine and Health Sciences, Other Pharmacy and Pharmaceutical Sciences, Pharmaceutics and Drug Design, Pharmacy and Pharmaceutical Sciences, Respiratory Tract Diseases, Therapeutics

File Description: application/pdf

Relation: https://dc.uthsc.edu/dissertations/628; https://dc.uthsc.edu/cgi/viewcontent.cgi?article=1628&context=dissertations

Availability: https://dc.uthsc.edu/dissertations/628
https://dc.uthsc.edu/cgi/viewcontent.cgi?article=1628&context=dissertations

Authors: Yuan, Dongfen, Rode, Frederik, Cao, Yanguang^{Aff1, Aff3}

Superior Title: The AAPS Journal: An Official Journal of the American Association of Pharmaceutical Scientists. 20(3)

Authors: Hardiansyah, Deni, Ng, Chee Meng^Aff1

Superior Title: Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. 35(3)

Authors: Chadha, Gurkishan S., Morris, Marilyn E.

Superior Title: The AAPS Journal: An Official Journal of the American Association of Pharmaceutical Scientists. November 2015 17(6):1464-1474

Authors: Zhao, Jie, Cao, Yanguang, Jusko, William J.

Superior Title: Pharmaceutical Research: An Official Journal of the American Association of Pharmaceutical Scientists. October 2015 32(10):3269-3281

Authors: Vivaswath S. Ayyar, Jong Bong Lee, Weirong Wang, Meghan Pryor, Yanli Zhuang, Thomas Wilde, An Vermeulen

Subject Terms: Pharmacology, Basic Pharmacology, Clinical Pharmacology and Therapeutics, Clinical Pharmacy and Pharmacy Practice, Pharmaceutical Sciences, Pharmacogenomics, Toxicology (incl. Clinical Toxicology), Pharmacology and Pharmaceutical Sciences not elsewhere classified, IL-17A, MBMA, mPBPK, psoriasis, target engagement, translational medicine, secukinumab, ixekizumab

Relation: https://figshare.com/articles/dataset/DataSheet1_Minimal_Physiologically-Based_Pharmacokinetic_mPBPK_Metamodeling_of_Target_Engagement_in_Skin_Informs_Anti-IL17A_Drug_Development_in_Psoriasis_DOCX/19646622

Availability: https://doi.org/10.3389/fphar.2022.862291.s001
https://figshare.com/articles/dataset/DataSheet1_Minimal_Physiologically-Based_Pharmacokinetic_mPBPK_Metamodeling_of_Target_Engagement_in_Skin_Informs_Anti-IL17A_Drug_Development_in_Psoriasis_DOCX/19646622